[Precise clinical classification of metabolic associated fatty liver disease]. [PDF]
Su WR, Ding JJ, Pan Q, Chai J.
europepmc +1 more source
[Advances in immunomodulatory strategies for meniscal regeneration]. [PDF]
Li J +7 more
europepmc +1 more source
[Research on ferroptosis induced by RSL3, Erastin, and TBHP in rat intervertebral disc annulus fibrosus cells]. [PDF]
Pan X, Tan J, Liu Y, Lei G, Lü F.
europepmc +1 more source
[Single<b>-</b>cell RNA sequencing reveals the driving mechanism of CXCL9<b>꞉</b>SPP1 polarization in the progression of non-alcoholic fatty liver disease]. [PDF]
Lu Y, Ni W, Chen R, Wang W.
europepmc +1 more source
[Research advances on the targeted programmed cell death regulatory network for treatment of refractory diabetic wounds]. [PDF]
Zhang ZH, He WF.
europepmc +1 more source
[Research progress on cellular metabolic reprogramming in skin fibrosis]. [PDF]
Qian S, Dai S, Guo C, Xu J.
europepmc +1 more source
[Determination of glufosinate and its metabolite residues in tea by ultra-high performance liquid chromatography-tandem mass spectrometry coupled with precolumn derivatization]. [PDF]
Bi RF +5 more
europepmc +1 more source
[Gut microbiota-associated metabolites with drug-induced liver injury]. [PDF]
Gao WK +5 more
europepmc +1 more source
[Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis]. [PDF]
Wang W, Zhao T, Wang YM, Xie O, Wang L.
europepmc +1 more source
[Research Progress on the Role and Mechanisms of PYCR1 in Tumorigenesis and Progression]. [PDF]
Meng Y, Yang Z, Feng H, Li H, Li B.
europepmc +1 more source

